Drug intelligence / Profile preview

Hyperol

Development stage
Phase 4
Lead developer
Meditop Pharmaceutical
Modality
Small Molecules
Administration
Topical
01

Overview

Hyperol is an approved topical antiseptic developed and manufactured by Meditop Pharmaceutical Ltd. Its active ingredient is carbamide peroxide (also known as urea hydrogen peroxide), a small molecule disinfectant that releases hydrogen peroxide and oxygen upon contact with water. This reaction provides a broad-spectrum antimicrobial effect, destroying bacteria, viruses, fungi, and other parasites. Hyperol is formulated as tablets intended to be dissolved in water to create a 3-30% solution for external use. It is indicated for the cleaning and disinfection of wounds, skin injuries, abrasions, and sores. The mechanical foaming action of the released oxygen gas helps to clean infections deep in tissue, reduce bleeding, and promote clotting. The product has been marketed in Hungary as a non-prescription antiseptic since 1995.

Brand names
Hyperol
Other names
carbamide peroxideurea hydrogen peroxideurea-hydrogen peroxide
02

Targets

DNA

Beyond the preview

Go deeper on Hyperol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyperol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call